Christopher Su

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study”.

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Cancer(2021)10.1002/cncr.34057

N/A

0.670DataRank · unranked

86 citations

Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman, Amanda Nizam +31 more

Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.01.006

N/A

0.396DataRank · unranked

13 citations

Christopher Su, Miriam M. Hu, Jeremy M. G. Taylor, Stephanie Daignault‐Newton, Olesia Kellezi +13 more

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01109-y

N/A

0DataRank · unranked

29 citations

J. Christine Ye, Christopher Su

Derivation of a Model to Guide Empiric Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection in an Endemic Area

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa070

N/A

0DataRank · unranked

6 citations

Fathima Jahufar, Nikhil Sharma, Christopher Su, Eran Bellin, Belinda Ostrowsky +1 more

Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19

medRxiv(2021)10.1101/2021.02.05.21250953

N/A

0DataRank · unranked

19 citations

Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri +16 more

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040

N/A

0DataRank · unranked

0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5

N/A

0DataRank · unranked

22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more